Mechanisms of electrochemotherapy.

Electrochemotherapy is a new therapeutic approach providing delivery into cell interiors of nonpermeant drugs with intracellular targets. It is based on the local application of short and intense electric pulses that transiently permeabilize cells in tissues. To date, its main application has been the treatment of tumor nodules when the electric pulses are associated with nonpermeant drugs having high intrinsic cytotoxicity. The most convenient drug is bleomycin, a currently used anticancer drug, but cytotoxicity of cisplatin is also increased in vivo by means of this original drug delivery approach. The efficacy of this new method is based on the following mechanisms: (i) electropermeabilization of cells in tissues; (ii) use of nonpermeant drugs having a high intrinsic cytotoxicity; (iii) existence of vascular effects due to the permeabilizing electric pulses; (iv) complementary role of the host's immune system. Preclinical trials have shown the efficacy of this new therapeutic modality in various tumor models. Clinical trials are in progress, demonstrating its feasibility in humans as well as the interest of the method.

[1]  L. Mir,et al.  Electrochemotherapy: variable anti-tumor effect on different tumor models , 1994 .

[2]  J. Lazo,et al.  Involvement of the cellular vacuolar system with the cytotoxicity of bleomycin-like agents. , 1990, Cancer Communications.

[3]  L. Mir,et al.  Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. , 1994, Biochimica et biophysica acta.

[4]  U. Zimmermann,et al.  Effect of medium conductivity and composition on the uptake of propidium iodide into electropermeabilized myeloma cells. , 1996, Biochimica et biophysica acta.

[5]  L. Mir,et al.  Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. , 1991, European journal of cancer.

[6]  L. Mir,et al.  Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. , 1991, Biochemical pharmacology.

[7]  S. Howell,et al.  Cellular accumulation of the anticancer agent cisplatin: a review. , 1993, British Journal of Cancer.

[8]  L. Mir,et al.  Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. , 1993, Cancer research.

[9]  F. Cortés,et al.  Induction of chromosomal aberrations in the CHO mutant EM9 and its parental line AA8 by EcoRI restriction endonuclease: electroporation experiments. , 1991, Mutation research.

[10]  F. Cortés,et al.  Chromosome damage induced by combined treatments with restriction endonucleases introduced into CHO cells by single or double electroporation. , 1995, Mutation research.

[11]  L. Mir,et al.  Systemic Antitumor Effects of Electrochemotherapy Combined with Histoincompatible Cells Secreting Interleukin‐2 , 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[12]  D. Miklavčič,et al.  Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice. , 1997, Cancer letters.

[13]  Franci Demsar,et al.  CONTRAST ENHANCED MRI ASSESSMENT OF TUMOR BLOOD VOLUME AFTER APPLICATION OF ELECTRIC PULSES , 1998 .

[14]  S. Orlowski,et al.  Electrochemotherapy on liver tumours in rabbits. , 1998, British Journal of Cancer.

[15]  A Brun,et al.  A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. , 1993, Biochemical and biophysical research communications.

[16]  L. Mir,et al.  Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. , 1992, European cytokine network.

[17]  M. Jaroszeski,et al.  Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. , 1997, Journal of the American Academy of Dermatology.

[18]  M. Jaroszeski,et al.  Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy , 1997, Melanoma research.

[19]  M J Jaroszeski,et al.  Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy , 1996, Cancer.

[20]  M. Jaroszeski,et al.  Electrochemotherapy: an emerging drug delivery method for the treatment of cancer. , 1997, Advanced drug delivery reviews.

[21]  M. Ogihara,et al.  Potentiation of antitumor effect of bleomycin by local electric pulses in mouse bladder tumor. , 1994, The Tohoku journal of experimental medicine.

[22]  U. Zimmermann,et al.  Electric field-mediated fusion and related electrical phenomena. , 1982, Biochimica et biophysica acta.

[23]  L. Mir,et al.  Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompotent and immunodeficient mice , 1997 .

[24]  M J Jaroszeski,et al.  In vivo antitumor effects of electrochemotherapy in a hepatoma model. , 1997, Biochimica et biophysica acta.

[25]  M. Okino,et al.  Optimal Electric Conditions in Electrical Impulse Chemotherapy , 1992, Japanese journal of cancer research : Gann.

[26]  T. Tsong,et al.  Formation and resealing of pores of controlled sizes in human erythrocyte membrane , 1977, Nature.

[27]  L. Mir,et al.  Electrochemotherapy, a new antitumor treatment. First clinical phase I‐II trial , 1993, Cancer.

[28]  T. Furukawa,et al.  Gene transfer into human leukemia cell lines by electroporation: experience with exponentially decaying and square wave pulse. , 1991, Leukemia research.

[29]  D Miklavcic,et al.  Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. , 1995, Cancer research.

[30]  M. Jaroszeski,et al.  Bleomycin-mediated electrochemotherapy of basal cell carcinoma. , 1996, Journal of the American Academy of Dermatology.

[31]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[32]  L. Mir,et al.  Cell electropermeabilization: a new tool for biochemical and pharmacological studies. , 1993, Biochimica et biophysica acta.

[33]  D. Chang,et al.  High efficiency gene transfection by electroporation using a radio-frequency electric field. , 1991, Biochimica et biophysica acta.

[34]  Damijan Miklavčič,et al.  Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice , 1996 .

[35]  L. Mir,et al.  Bleomycin: revival of an old drug. , 1996, General pharmacology.

[36]  L. Mir,et al.  Inhibition of tumor growth by histoincompatible cells expressing interleukin-2. , 1992, International Immunology.

[37]  J. Hamada,et al.  Possible participation of tumoricidal macrophages in the therapeutic effect of bleomycin on a transplantable rat fibrosarcoma. , 1986, Cancer research.

[38]  L. Mir,et al.  Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity. , 1994, Biochemical pharmacology.

[39]  M. Okino,et al.  Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. , 1987, Japanese journal of cancer research : Gann.

[40]  M. Rols,et al.  Ionic-strength modulation of electrically induced permeabilization and associated fusion of mammalian cells. , 1989, European journal of biochemistry.

[41]  D. Miklavčič,et al.  Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients , 1995 .

[42]  D. Miklavcic,et al.  Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. , 1998, British Journal of Cancer.

[43]  Evans Ga,et al.  Introduction and expression of DNA molecules in eukaryotic cells by electroporation. , 1988 .

[44]  J Teissié,et al.  Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. , 1990, Biophysical journal.

[45]  M. Jaroszeski,et al.  Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochem , 1995 .

[46]  J. Teissié,et al.  Reversible plasma membrane ultrastructural changes correlated with electropermeabilization in Chinese hamster ovary cells. , 1988, Biochimica et biophysica acta.

[47]  L. Mir,et al.  Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis. , 1995, Experimental cell research.

[48]  Damijan Miklavčič,et al.  Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy , 1995 .

[49]  S. Orlowski,et al.  First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. , 1997, British Journal of Cancer.

[50]  W. Webb,et al.  Optical imaging of cell membrane potential changes induced by applied electric fields. , 1986, Biophysical journal.

[51]  M. Hosokawa,et al.  Overcoming suppression of antitumor immune reactivity in tumor-bearing rats by treatment with bleomycin. , 1988, Cancer research.

[52]  M. Hirata,et al.  Effects of electrochemotherapy on CaSki cells derived from a cervical squamous cell carcinoma. , 1997, Gynecologic oncology.

[53]  L. Mir,et al.  Electrochemotherapy of spontaneous mammary tumours in mice. , 1991, European journal of cancer.

[54]  J. Belehradek,et al.  Identification of a plasma membrane protein that specifically binds bleomycin. , 1993, Biochemical and Biophysical Research Communications - BBRC.

[55]  L. Mir,et al.  Antitumor electrochemotherapy: New advances in the clinical protocol , 1996, Cancer.

[56]  L. Mir,et al.  Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. , 1988, Biochemical pharmacology.

[57]  J. Hamada,et al.  Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma. , 1985, Cancer research.

[58]  P. Seglen,et al.  Increase in cis-dichlorodiammineplatinum (II) cytotoxicity upon reversible electropermeabilization of the plasma membrane in cultured human NHIK 3025 cells. , 1986, European journal of cancer & clinical oncology.

[59]  Ulrich Zimmermann,et al.  Dielectric Breakdown of Cell Membranes , 1974 .

[60]  L. Mir,et al.  Voltage-dependent introduction of a d[α]octothymidylate into electropermeabilized cells , 1989 .

[61]  E. Neumann,et al.  Membrane electroporation and direct gene transfer , 1992 .

[62]  M. Mitchell.  Combining chemotherapy with biological response modifiers in treatment of cancer. , 1988, Journal of the National Cancer Institute.

[63]  L. Mir,et al.  Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. , 1988, Experimental cell research.